Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
1.090
-0.040 (-3.54%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Immuron Market Cap
Immuron has a market cap or net worth of $8.98 million as of October 2, 2026. Its market cap has decreased by -19.82% in one year.
Market Cap
8.98M
Enterprise Value
2.84M
1-Year Change
-19.82%
Ranking
Category
Stock Price
$1.09
ChartMarket Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $8.98M, a decrease of -68.04%. That is a compound annual growth rate of -11.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 8.80M | 95.56% |
| Dec 31, 2025 | 4.50M | -53.61% |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
| Jun 9, 2017 | 28.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MetaVia | 10.15M |
| Senti Biosciences Holdings | 10.04M |
| Moolec Science | 9.88M |
| Moleculin Biotech | 9.48M |
| Aprea Therapeutics | 8.75M |
| Traws Pharma | 8.74M |
| FibroBiologics | 8.63M |
| Longeveron | 8.23M |